Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Intel is turning its chip contract manufacturing business into an independent subsidiary, and Microsoft boosts its quarterly ...

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

Jim Cramer’s 10 Best Stock Picks for Investors Right Now. In this article, we are going to take a look at where Moderna, Inc.

Moderna shares are down for the second day in a row after the company said it would slash its research and development costs.

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...